BioVectra DCL

Learn about the biggest trends impacting small-molecule APIs, excipients, and formulations, key sessions to attend while at CPHI, innovations and novel approaches for pediatric dosage forms and taste-masking, and fundamental aspects of API manufacturing and distribution from a panel of experts who have contributed to this year’s CPHI Annual Report, David Tisi from Synopsys, and an SME from C2 Pharma in this episode of the PharmTech Drug Digest Video Series.

https://www.pharmtech.com/pt_w/big-impact

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, 

Group, interviews experts about small-molecule APIs, excipients, and formulation advances. During the video session, a panel of experts—Bikash Chatterjee, Tara Dougal —deliberate on the biggest trends impacting the industry, highlighting issues such as API supply and shortages, uptake in digital innovations, formulation advances to deal with potent compounds, and key sessions to visit while at CPHI. Additionally, David Tisi, director of Technical Operations, Synopsys, discusses novel approaches and solutions to pediatric formulations and taste-masking, while an expert from C2 Pharma highlights the fundamental stages of gaining a certificate of suitability for APIs and the various trends shaping API and complex compound manufacturing.
Interviews featuring:

Bikash Chatterjee, president and chief science officer at PharmTech Associates

Tara Dougal, content director—Pharma, Informa Markets

Tara Fitzpatrick, head of Quality, C2 Pharma

This episode of Drug Digest is sponsored by:

Trends impacting small-molecule APIs, excipients, and formulation markets.

Innovations benefitting API and excipient developers and formulation scientists.

Novel approaches to pediatric formulations.

Fundamental stages of gaining a certificate of suitability.


Director of Technical Operations
Synopsys


Webcasts

Webinar Date/Time: Thursday, September 21, 2023 at 11am ET | 10am CT | 8am PT | 4 pm BST

BioVectra DCL

Articles